Clinical Trials List
2013-03-01 - 2019-10-31
Phase III
Terminated8
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 徐思淳 Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- 蔡偉 Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Tung-Liang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Huai-Hsuan Huang Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- 賴冠銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林柏翰 Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
520 participants
